Lymph node ratio and pN staging in patients with node-positive breast cancer: A report from the Korean breast cancer society

Breast Cancer Research and Treatment

Volumn 130, Issue 2, 2011, Pages 507-515

  Ahn, Sei Hyun ^a   Kim, Hee Jeong ^a   Lee, Jong Won ^a   Gong, Gyung Yub ^a   Noh, Dong Yong ^b   Yang, Jung Hyun ^c   Jung, Sang Seol ^d   Park, Ho Yong ^e  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Kyungpook National University School of Medicine   (South Korea)

Author keywords

Her2 neu; Lymph node; Lymph node ratio; Triple negative; Young breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; KOREA; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL SOCIETY; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TRIPLE NEGATIVE BREAST CANCER;

ADULT; ANALYSIS OF VARIANCE; BREAST NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS;

EID: 82955247925     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1730-9     Document Type: Article

References (35)

1. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB et al (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52:1551-1557 (Pubitemid 13018271)
2. Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA (2010) Improved staging in node-positive breast cancer patients using lymph node ratio: results in 1,788 patients with long-term follow-up. J Am Coll Surg 210:797-805
3. Truong PT, Woodward WA, Thames HD, Ragaz J, Olivotto IA, Buchholz TA (2007) The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differ-ences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: an analysis ofprospective data from British Columbia and the M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 68:59-65 (Pubitemid 46589833)
4. Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G et al (2009) Lymph node ratio as an alter-native to p N staging in node-positive breast cancer. J Clin Oncol 27:1062-1068
5. Woodward WA, Vinh-Hung V, Ueno NT, Cheng YC, Royce M, Tai P et al (2006) Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol 24:2910-2916 (Pubitemid 46630594)
6. Hatoum HA, Jamali FR, El-Saghir NS, Musallam KM, Seoud M, Dimassi H et al (2009) Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer. Ann Surg Oncol 16:3388-3395
7. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP (2008) Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 206:239-246
8. Chan JK, Kapp DS, Cheung MK, Osann K, Shin JY, Cohn D et al (2007) The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer 97:605-611 (Pubitemid 47339879)
9. Hyung WJ, Noh SH, Yoo CH, Huh JH, Shin DW, Lah KH et al (2002) Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 26:323-329 (Pubitemid 36920410)
10. Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the Ger-man gastric cancer study. Ann Surg 228:449-461 (Pubitemid 30194389)
11. Berger AC, Watson JC, Ross EA, Hoffman JP (2004) The met-astatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarci-noma. Am Surg 70:235-240 (discussion 240)
12. Herr HW (2003) Superiority of ratio based lymph node staging for bladder cancer. J Urol 169:943-945 (Pubitemid 36188130)
13. Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E (2005) Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high post-mastectomy locoregional recurrence risk for adjuvant radiother-apy. Int J Radiat Oncol Biol Phys 61:1337-1347 (Pubitemid 40470413)
14. Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS et al (2007) Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea\-a report from the Korean breast cancer society. J Clin Oncol 25:2360-2368 (Pubitemid 47007614)
15. Bland KI, Scott-Conner CE, Menck H, Winchester DP (1999) Axillary dissection in breast-conserving surgery for stage I and II breast cancer: a national cancer data base study of patterns of omission and implications for survival. J Am Coll Surg 188:586-595 (discussion 595-586)
16. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087-2106 (Pubitemid 41797643)
17. Ibrahim EM, Elkhodary TR, Zekri JM, Bahadur Y, El-Sayed ME, Al-Gahmi AM et al (2010) Prognostic value of lymph node ratio in poor prognosis node-positive breast cancer patients in Saudi Arabia. Asia Pac J Clin Oncol 6:130-137
18. Bollet MA, Sigal-Zafrani B, Mazeau V, Savignoni A, de la Rochefordière A, Vincent-Salomon A et al (2007) Age remains the first prognostic factor for loco-regional breast cancer recur-rence in young (<40 years) women treated with breast conserving surgery first, Radiother Oncol, 82, 272-280 (Pubitemid 46350796)
19. Coulombe G, Tyldesley S, Speers C, Paltiel C, Aquino-Parsons C, Bernstein V et al (2007) Is mastectomy superior to breast-conserving treatment for young women? Int J Radiat Oncol Biol Phys 67:1282-1290 (Pubitemid 46467166)
20. Punglia RS, Morrow M, Winer EP, Harris JR (2007) Local therapy and survival in breast cancer. N Engl J Med 356: 2399-2405
21. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684-1691
22. Millar EKA, Graham PH, O'Toole SA, Mc Neil CM, Browne L, Morey AL et al (2009) Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27:4701-4708
23. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL et al (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26:2373-2378
24. Gervasoni JE, Taneja C, Chung MA, Cady B (2000) Biologic and clinical significance of lymphadenectomy. Surg Clin North Am 80:1631-1673 (Pubitemid 32006385)
25. Greco M, Gennaro M, Valagussa P, Agresti R, Ferraris C, Ferrari B et al (2000) Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori. Ann Oncol 11:1137-1140
26. Cady B (2000) A contemporary view of axillary dissection. Ann Surg 232:8-9 (Pubitemid 30456544)
27. Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247-253 (Pubitemid 46350797)
28. Cheng JC, Chen CM, Liu MC, Tsou MH, Yang PS, Jian JJ et al (2002) Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 52:980-988 (Pubitemid 34219017)
29. Yang PS, Chen CM, Liu MC, Jian JM, Horng CF, Liu MJ et al (2010) Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status. Int J Radiat Oncol Biol Phys 77:516-522
30. Chen JJ, Wu J (2010) Management strategy of early-stage breast cancer patients with a positive sentinel lymph node: With or without axillary lymph node dissection. Crit Rev Oncol Hematol 79(3):293-301
31. Moghaddam Y, Falzon M, Fulford L, Williams NR, Keshtgar MR (2010) Comparison of three mathematical models for predicting the risk of additional axillary nodal metastases after positive sentinel lymph node biopsy in early breast cancer. Br J Surg. doi: 10.1002/bjs.7181
32. van den Hoven I, Kuijt GP, Voogd AC, van Beek MW, Roumen RM (2010) Value of memorial Sloan-Kettering cancer center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg. doi:10.1002/bjs.7186
33. Jakub JW, Bryant K, Huebner M, Hoskin T, Boughey JC, Rey-nolds C et al. (2010) The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes. Ann Surg Oncol. doi:10.1245/s10434-010-1202-1
34. Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S (2005) An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113-119 (Pubitemid 40684923)
35. Punglia RS, Morrow M, Winer EP, Harris JR (2007) Local therapy and survival in breast cancer. N Engl J Med 356: 2399-2405